中新社深圳12月5日电 (记者 郑小红)国际癌症基因组联盟(ICGC)5日在多伦多宣布在中国发起4个新项目，主要对结直肠癌、食道癌、肝癌和鼻咽癌的驱动基因进行检测，为实现个体化医疗奠定基础。

China news agency shenzhen on December 5, (Reporter ZhengXiaoGong)International cancer genome alliance(ICGC)5, announced in Toronto in China has launched four new project,Mainly to colorectal cancer/Esophageal cancer/Liver cancer and nasopharyngeal carcinoma drive gene were detected,Lay the foundation for the realization of individual medical treatment.

　　ICGC由遍布全球的诸多研究机构组成，带领全球科学家对各种常见和罕见的癌症进行基因组图谱绘制，主要目标是在全球范围内，对社会和临床具有重要意义的50多种癌症的25000多个癌症患者进行致癌突变检测，并使所产出的数据能够被快速和免费使用。中国是ICGC的创始成员之一，在2008年时曾经发起了胃癌基因组项目。

ICGC around the world by many research institutions composition,Leading scientists all over the world to all sorts of common and rare cancer genome atlas on drawing,The main goal is in the global scope,On social and clinical significant fifty many cancer more than 25000 cancer patients with cancer mutation detection,And so that the output data can be quick and free to use.China is one of the ICGC founding member,In 2008 once launched gastric cancer genome project.

　　中国癌症基因组联盟(CCGC)5日向深圳媒体透露，CCGC合作计划已经形成了一个具有200多位精通新一代基因组测序以及生物信息学技术的科研人员网络体系，揭示癌症的各种复杂起因。这4个新项目的研究人员来自北京、上海、广州、深圳和香港等12个城市的19个医院或研究所。

Chinese cancer genome alliance(CCGC)5 days to the shenzhen media,CCGC cooperation plan has been formed a has more than 200 master a new generation of genome sequencing and bioinformatics technology researchers network system,Reveals the various complicated causes cancer.These four new project researchers from Beijing/Shanghai/guangzhou/Shenzhen and Hong Kong and other 12 cities 19 a hospital or institute.

　　新项目中所涉及到的这几种类型的癌症，在中国远比其他国家或地区更为常见。胃癌、食道癌和肝癌在中国的发病率是世界其他地方的两倍；鼻咽癌患者有70%都在中国。

The new project involved the several types of cancer,In China than other countries or regions more common.Gastric cancer/Esophageal cancer and liver cancer incidence in China is two times in other parts of the world;Nasopharyngeal carcinoma patients were 70% in China.

　　在中国，癌症是造成死亡的主要原因之一，约有四分之一的死亡与癌症相关，并且癌症的发病率仍在迅速增长。目前，每年约有270万人被诊断为癌症，190万患者死于癌症。ICGC在法国、日本、英国和美国的团队所主导的食道癌、肝癌和结直肠癌基因组项目的实施，将使不同国家不同人种之间的比较研究成为可能。

In China,Cancer is one of the main reasons to cause death,About a quarter of death associated with cancer,And the incidence of cancer is still in the rapid growth.At present,Each year about 2.7 million people have been diagnosed with cancer,1.9 million patients died of cancer.ICGC in France/Japan/Britain and the United States team dominated esophageal cancer/Liver cancer and colorectal cancer genome project implementation,Different countries will make a comparative study between different ethnic become possible.

　　截至2012年12月，ICGC已经收到来自亚洲、澳大利亚、欧洲和北美在15个行政辖区的51个项目团队的承诺，将进行超过25000个肿瘤基因组的研究。

As of December 2012,ICGC have received from Asia/Australia/Europe and North America in 15 jurisdictions 51 a commitment to the project team,Will be more than 25000 cancer genome research.

　　每一个ICGC项目团队都将对至少一种特殊类型或亚型的癌症进行全基因组范围内全面高通量的分析，并对数据采集和分析建立统一的标准进行研究。(完)

Every ICGC project team will be on at least one kind of special type or subtype of cancer to carry out the whole genome range comprehensive high throughput analysis,And the data collection and analysis to establish unified standard for research.(finish)